Abstract
Adalimumab is a human monoclonal antibody against tumour necrosis factor-alpha that has been associated with acute lung toxicity, mainly in patients with rheumatoid arthritis. Descriptions of similar patterns of lung injury in patients treated with adalimumab for inflammatory bowel disease are emerging in the literature. A case involving a 45-year-old man with Crohn's disease who developed a nonbronchiolitis inflammatory nodular pattern of lung injury after starting adalimumab is reported. ©2011 Pulsus Group Inc. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Reid, J. D., Bressler, B., & English, J. (2011). A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn’s disease. Canadian Respiratory Journal, 18(5), 262–264. https://doi.org/10.1155/2011/713821
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
